Table 1 Characteristics of patients with autoimmune hepatitis
From: Interleukin-21 plays a critical role in the pathogenesis and severity of type I autoimmune hepatitis
Age (year) | 58.6 ± 11.7 |
Gender (male/female) | 4/18 |
Onset type (acute/chronic) | 11/11 |
AIH score (revised) | 15.1 ± 4.0 |
AIH score (simplified) | 6.2 ± 1.3 |
AST (U/l) | 613.4 ± 831.1 |
ALT (U/l) onset/remission | 537.8 ± 732.1/13.3 ± 6.9 |
ALP (U/l) onset/remission | 440.8 ± 240.6/239.8 ± 81.6 |
Alb (g/dl) | 3.3 ± 0.7 |
TB (mg/dl) onset/remission | 7.3 ± 9.7/0.9 ± 0.4 |
PT (%) | 72.9 ± 22.9 |
PLT (×104/μl) | 15.0 ± 5.1 |
IgG (mg/dl) onset/remission | 2604.1 ± 1021.7/1236.5 ± 249.6 |
ANA (median) | 160 |
Relapse n (%) | 7 (31.8) |
Grading of necroinflammatory activity 0/1/2/3/4 (n) | 0/2/9/7/1 |
Staging of fibrosis 0/1/2/3/4 (n) | 2/4/5/6/2 |
UDCA monotherapy n (%) | 3 (13.6) |
PSL monotherapy n (%) | 16 (72.7) |
PSLÂ +Â AZA n (%) | 3 (13.6) |